Loading preview choices…

Advantage / Indigo / The Arch

A soft frame for a product leader who removes things

Indigo / The Arch introduces its leader as a person first and a record second, which suits a chief product officer whose best evidence is restraint. The fictional Luca Duvall runs product for Merlicourt Orthopaedics, a family-controlled Belgian maker of hip and knee implants, instruments and a recovery app. His cases concern a knee system withdrawn, a messaging feature ended and a commercial advantage given away, decisions that are hard to present without sounding defensive. The design gives him a calm opening, then lets seven pages carry the figures and history a medtech chair will check.

An opening that leads with a sentence about patients

On a wide screen the home page sets the portrait inside a fine outlined arch, captioned with his market, Europe. Beside it sit his role, the authored heading "The recovery belongs to the product" and, beneath it in large Crimson Pro, his headline about a patient's kitchen three weeks after surgery. An availability line shows he is open to board conversations only. On a phone the words arrive first. Either way, the first thing a reader meets is the user he designs for, not a list of launches.

A centred conviction and three voices

Below the opening, the structure places the leader's philosophy as a centred quotation under a large violet quotation mark, signed with his name. Luca's passage argues that an implant outlives the people who choose it, which prepares the reader for decisions about support and withdrawal. Three headline figures follow: group revenue, the 96 hospitals using the recovery app and his 74 product colleagues. Under "Leadership, seen by others." a customer's head of physiotherapy, the quality director and the chief executive each describe a different working relationship. All three are invented here; a real leader should quote only people who have approved their words.

Why indigo, Crimson Pro and Figtree suit a regulated product audience

The Indigo palette pairs a pale lavender ground with deep violet accents and dark plum ink. It reads as clinical without the familiar hospital blue, giving a medical-device executive a more personal register than a corporate brochure. Crimson Pro, a book serif, carries headings, the thesis and testimony. Figtree, a clear sans-serif, handles navigation, captions, dates and figures, where a reader checking a device class or budget needs plain legibility. The masthead sets the name in italics and turns page links into soft pills.

The selected case and the authored home

A rounded panel on the surface colour introduces the first decision, the withdrawal of a 2004 knee system, with its opening sentence and a link to the full work. The authored home follows: an italic thesis, three introductory paragraphs, three proof points and notes on current focus and welcome conversations. The proof points carry the numbers a medtech director would query first: a €3.1 million certification estimate against €7.4 million of declining sales, 412 unread patient messages and adoption rising from 61 to 96 hospitals. A short record shows his engineering formation, and a dark panel repeats his conditions for one non-executive role.

Biography, practice and decisions on the inner pages

The profile page sets the biography beside a portrait cropped to the same arch, followed by the conviction, the figures and a record of education and colleague perspectives. It begins with a surgeon struggling with a cutting guide in 1999. The expertise page numbers five areas, from MDR portfolio choices to recovery design for patients in their seventies. The impact page gives each decision its own numbered article, keeping its cost, its opponents and what Luca would now change in one continuous reading.

Career chapters and a board page shaped like a conversation

The career page opens beneath a broad arched header on the surface colour, then presents six appointments as centred chapters with a violet rule beside each date and title. The route runs from a Grenoble design office through a Turin hip range to four roles in Namur, each chapter keeping reporting line, team, budget and outcomes together. Readiness places his proposed contribution inside an outlined arch, then sets two judgement examples beside commitment, committee and learning details, with his exposure as a presenter, not a director, stated below. Both pages print cleanly for committee packs.

Who else this design suits

The Arch suits leaders whose authority comes from how they work with others: product, people, medical or customer executives whose strongest evidence is testimony backed by a careful record. The indigo palette suits healthcare, life sciences, education and professional services, where a quieter colour signals seriousness without severity. It is less suitable for a leader whose case rests on one dramatic number, or who has no colleagues willing to be quoted.

Questions about this design

Does an arched, testimony-led design undersell a medical-device executive?
Not when the inner pages carry the evidence. Here the opening introduces Luca through his headline and colleagues, while the cases, career chapters and readiness page hold certification costs, adoption figures, reporting lines and conflicts. Proof is one click away.
How should a product leader present a product withdrawal?
Show the cost of continuing, the cost of stopping and the obligations that remain after the last sale. Name who disagreed, explain the transition offered to users and give the outcome with figures, including customers lost.
Can a European executive with no directorship use the board page credibly?
Yes, if the page is precise about capacity. Luca presents to his company's board and reports to its quality committee, and the page says he has never been a director. It names the committees he could join, the relationships that would rule a seat out and the time he can offer.
What material should be ready before choosing this design?
A portrait with space for an arched crop, a one-paragraph conviction, two or three consented endorsements, three decisions with their trade-offs, a dated record of five to seven appointments and a considered view of board contribution.